NEOSAR Drug Patent Profile
✉ Email this page to a colleague
When do Neosar patents expire, and what generic alternatives are available?
Neosar is a drug marketed by Bedford and Teva Parenteral and is included in two NDAs.
The generic ingredient in NEOSAR is cyclophosphamide. There is one drug master file entry for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the cyclophosphamide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Neosar
A generic version of NEOSAR was approved as cyclophosphamide by BAXTER HLTHCARE on May 21st, 2008.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NEOSAR?
- What are the global sales for NEOSAR?
- What is Average Wholesale Price for NEOSAR?
Summary for NEOSAR
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 420 |
| DailyMed Link: | NEOSAR at DailyMed |
Recent Clinical Trials for NEOSAR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Southern California | Phase 1 |
| Fred Hutchinson Cancer Center | Phase 2 |
| National Cord Blood Network | Phase 2 |
US Patents and Regulatory Information for NEOSAR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bedford | NEOSAR | cyclophosphamide | INJECTABLE;INJECTION | 087442-004 | Jul 8, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva Parenteral | NEOSAR | cyclophosphamide | INJECTABLE;INJECTION | 040015-005 | Apr 29, 1993 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bedford | NEOSAR | cyclophosphamide | INJECTABLE;INJECTION | 087442-002 | Feb 16, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva Parenteral | NEOSAR | cyclophosphamide | INJECTABLE;INJECTION | 040015-001 | Apr 29, 1993 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bedford | NEOSAR | cyclophosphamide | INJECTABLE;INJECTION | 087442-005 | Mar 30, 1989 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bedford | NEOSAR | cyclophosphamide | INJECTABLE;INJECTION | 087442-001 | Feb 16, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva Parenteral | NEOSAR | cyclophosphamide | INJECTABLE;INJECTION | 040015-004 | Apr 29, 1993 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
